Genetic signatures for colon cancer

Prof Pierre Laurent-Puig - University of Paris, France
Genetic signatures for colon cancer ( Prof Pierre Laurent-Puig - University of Paris, France )
23 Jul 2012

Colorectal cancer in the elderly

Dr Demetris Papamichael - BO Cyprus Oncology Centre, Nicosia, Cyprus
Colorectal cancer in the elderly ( Dr Demetris Papamichael - BO Cyprus Oncology Centre, Nicosia, Cyprus )
23 Jul 2012

The EUREKA Initiative

Prof Cornelius van de Velde - Leiden University Medical Center, Netherlands
The EUREKA Initiative ( Prof Cornelius van de Velde - Leiden University Medical Center, Netherlands )
23 Jul 2012

Prevention best ‘treatment’ for colon cancer

Prof Nadir Arber – Integrated Cancer Prevention Center, Tel Aviv Medical Center, Israel
Prevention best ‘treatment’ for colon cancer ( Prof Nadir Arber – Integrated Cancer Prevention Center, Tel Aviv Medical Center, Israel )
20 Jul 2012

Bevacizumab benefits beyond progression in TML study subgroups

Dr Thierry André – Hôpital Saint Antoine, Paris, France
Bevacizumab benefits beyond progression in TML study subgroups ( Dr Thierry André – Hôpital Saint Antoine, Paris, France )
17 Jul 2012

Pharmacodynamic endpoints need to be included in GI trials

Prof Fortunato Ciardiello – Seconda Università degli Studi di Napoli, Italy
Pharmacodynamic endpoints need to be included in GI trials ( Prof Fortunato Ciardiello – Seconda Università degli Studi di Napoli, Italy )
17 Jul 2012

Exploring new targets in GI cancer

Prof Josep Tabernero – Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
Exploring new targets in GI cancer ( Prof Josep Tabernero – Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain )
17 Jul 2012

Unravelling mechanisms of resistance to targeted drugs

Prof Salvatore Siena – Niguarda Ca’ Granda Hospital, Milan, Italy
Unravelling mechanisms of resistance to targeted drugs ( Prof Salvatore Siena – Niguarda Ca’ Granda Hospital, Milan, Italy )
17 Jul 2012

CORRECT study data prompts US FDA priority review

Prof Alberto Sobrero – Ospedale San Martino, Genova, Italy
CORRECT study data prompts US FDA priority review ( Prof Alberto Sobrero – Ospedale San Martino, Genova, Italy )
17 Jul 2012

Anti-angiogenic trials; key highlights of the 14th WCGC

Prof Eric Van Cutsem – University Hospital Leuven, Gasthuisberg, Belgium
Anti-angiogenic trials; key highlights of the 14th WCGC ( Prof Eric Van Cutsem – University Hospital Leuven, Gasthuisberg, Belgium )
17 Jul 2012

Epigenetics of cancer and changes in DNA modification in tumours

Prof Manel Esteller – University of Barcelona, Catalonia, Spain
Epigenetics of cancer and changes in DNA modification in tumours  ( Prof Manel Esteller – University of Barcelona, Catalonia, Spain   )
16 Jul 2012

Perifosine disappoints in refractory mCRC

Dr Johanna Bendell – Sarah Cannon Research Institute, Nashville, USA
Perifosine disappoints in refractory mCRC ( Dr Johanna Bendell – Sarah Cannon Research Institute, Nashville, USA )
16 Jul 2012